TheraNovex TrialMatch Reaches Global Milestone: Connects 143,000 Unique Clinical Research Sites Across 237 Countries

Miami, Florida – April 25, 2026 – TheraNovex, an innovator in AI-powered clinical trial recruitment and site intelligence, today announced a major milestone for its flagship platform, TheraNovex TrialMatch, which now connects 143,000 unique clinical research sites across 237 countries —making it one of the largest and most comprehensive global site intelligence platforms in the clinical research industry.

As clinical trials continue to expand across international markets, sponsors and CROs face increasing challenges identifying qualified, high-performing research sites quickly and efficiently. TrialMatch was built to solve this problem by aggregating, validating, deduplicating, and standardizing site data from multiple global registries into one unified intelligence platform.

This milestone positions TrialMatch as a powerful solution for pharmaceutical sponsors, contract research organizations, and research organizations seeking faster feasibility assessments, smarter site selection, and broader access to qualified global sites.

"Reaching 143,000 clinical research sites across 237 countries represents a major leap forward in how sponsors identify and engage research sites worldwide," said Tricia Barrios, Co-Founder of TheraNovex . "The clinical trial industry has historically relied on fragmented systems and disconnected regional databases. TrialMatch changes that by providing a single, unified source of truth for site intelligence, helping sponsors reduce startup timelines and accelerate access to innovative treatments."

Unlike traditional U.S.-focused site directories, TrialMatch provides deep international visibility into sites across Europe, Asia, Latin America, and emerging global markets, enabling broader study access and stronger geographic diversity in clinical trials.

Powered by advanced analytics and AI-driven filtering, TrialMatch allows sponsors and CROs to evaluate sites based on:

Therapeutic area expertise Historical trial participation Site activity status Geographic location Research capabilities Global regulatory jurisdiction

Global Scale at Unprecedented Depth Access to 143,000 verified clinical research sites across 237 countries.

Multi-Registry Intelligence Aggregation Consolidated data from multiple international trial registries and public data sources.

Advanced Site Discovery and Filtering Search by indication, therapeutic area, geography, and operational status.

Accelerated Feasibility and Site Selection Reduce weeks of manual site identification into minutes.

Sponsor-to-Site Connectivity Directly connect sponsors and CROs with research sites through enhanced site profiles and capability visibility.

This milestone reinforces TheraNovex's broader mission to modernize clinical trial operations through AI-powered infrastructure, improving not only site discovery but also patient recruitment, retention, and operational workflows.

As the company continues to expand its ecosystem, TrialMatch will remain central to its vision of building a smarter, faster, and more connected future for clinical research.

For more information about TheraNovex TrialMatch, visit TheraNovex.com .

TheraNovex is an AI-driven clinical trial technology company focused on transforming patient recruitment, site operations, and sponsor feasibility through intelligent automation and data-driven solutions. Its growing suite of tools helps research sites and sponsors accelerate study timelines, improve enrollment efficiency, and streamline clinical operations worldwide.

Tricia Barrios Co-Founder, TheraNovex support@theranovex.com TheraNovex.com